Raia Drogasil S.A.
RADLY
$3.56
-$0.26-6.81%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.12% | 27.25% | 29.78% | 14.83% | -4.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.12% | 27.25% | 29.78% | 14.83% | -4.35% |
| Cost of Revenue | 16.11% | 24.17% | 30.17% | 15.33% | -5.54% |
| Gross Profit | 28.98% | 34.29% | 28.86% | 13.65% | -1.63% |
| SG&A Expenses | 28.03% | 29.47% | 23.65% | 12.76% | -1.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 612.59% | 918.32% | -- | -- | -89.34% |
| Total Operating Expenses | 19.26% | 28.42% | 28.49% | 14.69% | -4.50% |
| Operating Income | 31.58% | 5.94% | 53.17% | 16.88% | -2.29% |
| Income Before Tax | 53.92% | -14.44% | 16.30% | 25.77% | -16.66% |
| Income Tax Expenses | 136.91% | -198.68% | 120.08% | -17.07% | -44.47% |
| Earnings from Continuing Operations | 40.44% | 15.55% | -10.22% | 38.63% | -9.28% |
| Earnings from Discontinued Operations | -84.58% | -42.70% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 12,761.84% | -91.34% | -302.91% |
| Net Income | 24.17% | 8.24% | -5.81% | 37.98% | 5.31% |
| EBIT | 31.58% | 5.94% | 53.17% | 16.88% | -2.29% |
| EBITDA | 27.36% | 10.67% | 54.64% | 14.61% | -0.17% |
| EPS Basic | 26.46% | 10.18% | 2.53% | 38.16% | 83.64% |
| Normalized Basic EPS | 57.32% | -24.19% | 39.71% | 7.58% | 40.59% |
| EPS Diluted | 25.06% | 7.83% | 2.25% | 37.82% | 82.71% |
| Normalized Diluted EPS | 57.02% | -26.61% | 39.22% | 7.22% | 38.24% |
| Average Basic Shares Outstanding | -1.96% | -1.89% | -7.96% | -0.10% | -42.53% |
| Average Diluted Shares Outstanding | -1.96% | 0.33% | -7.72% | 0.11% | -41.55% |
| Dividend Per Share | -- | -- | -- | -34.80% | -- |
| Payout Ratio | -0.30% | 3.96% | 0.68% | -0.95% | 0.13% |